Insider Transactions in Q3 2021 at Allovir, Inc. (ALVR)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,171
-2.8%
|
$304,275
$25.17 P/Share
|
Sep 29
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.23%
|
$25,000
$25.04 P/Share
|
Sep 28
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,750
-0.79%
|
$90,000
$24.12 P/Share
|
Sep 17
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,950
-0.62%
|
$70,800
$24.01 P/Share
|
Sep 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,916
-1.34%
|
$147,900
$25.08 P/Share
|
Sep 15
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
800
-0.17%
|
$19,200
$24.03 P/Share
|
Sep 02
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
513
-0.12%
|
$9,747
$19.86 P/Share
|
Aug 17
2021
|
Jeroen B Van Beek Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,205
-3.33%
|
$258,485
$17.82 P/Share
|
Jul 02
2021
|
Agustin Melian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,586
-3.73%
|
$353,134
$19.99 P/Share
|